Venmax Drugs and Pharmaceuticals informs about revised outcome of board meeting

18 Feb 2023 Evaluate
Venmax Drugs and Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on Monday, the 30th January, 2023 at 4.00 PM at registered office of the Company, approved the un-audited Financial Results for the Quarter (Q3) and Nine Months ended December 31, 2022. The meeting commenced at 4.00 pm and concluded at 4.30 pm.

The above information is a part of company’s filings submitted to BSE.

Venmax Drugs&Pharma Share Price

27.60 -1.40 (-4.83%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×